JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

Home・Aandelen Lijst・Celsion Corp

Celsion Corp

Gesloten

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken
By Trading Economics
Werknemers	25

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-9.9M 938K
Vorige openingsprijs	0
Vorige sluitingsprijs	0

Celsion Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 okt 2025, 17:40 UTC

Acquisities, Fusies, Overnames

Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion

1 nov 2025, 12:56 UTC

Winsten

Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ

1 nov 2025, 12:56 UTC

Winsten

Acquisities, Fusies, Overnames

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 nov 2025, 12:20 UTC

Winsten

Acquisities, Fusies, Overnames

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 nov 2025, 12:19 UTC

Winsten

Acquisities, Fusies, Overnames

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 nov 2025, 08:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

1 nov 2025, 08:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

1 nov 2025, 00:10 UTC

Winsten

Trouble on The Strip -- Barrons.com

31 okt 2025, 23:09 UTC

Winsten

Review & Preview: October Surprise -- Barrons.com

31 okt 2025, 22:44 UTC

Acquisities, Fusies, Overnames

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 okt 2025, 21:25 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31 okt 2025, 21:20 UTC

Acquisities, Fusies, Overnames

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31 okt 2025, 21:12 UTC

Acquisities, Fusies, Overnames

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31 okt 2025, 21:12 UTC

Acquisities, Fusies, Overnames

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 okt 2025, 21:12 UTC

Acquisities, Fusies, Overnames

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31 okt 2025, 20:51 UTC

Acquisities, Fusies, Overnames

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31 okt 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

31 okt 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

31 okt 2025, 20:50 UTC

Marktinformatie

Winsten

Auto & Transport Roundup: Market Talk

31 okt 2025, 20:46 UTC

Acquisities, Fusies, Overnames

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31 okt 2025, 20:22 UTC

Winsten

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31 okt 2025, 20:02 UTC

Winsten

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31 okt 2025, 19:55 UTC

Marktinformatie

Crude Futures Fall for Third Straight Month -- Market Talk

31 okt 2025, 19:54 UTC

Acquisities, Fusies, Overnames

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31 okt 2025, 19:54 UTC

Acquisities, Fusies, Overnames

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31 okt 2025, 19:26 UTC

Marktinformatie

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31 okt 2025, 18:30 UTC

Winsten

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31 okt 2025, 18:23 UTC

Marktinformatie

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31 okt 2025, 18:09 UTC

Winsten

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31 okt 2025, 18:08 UTC

Winsten

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

Peer Vergelijking

Prijswijziging

Celsion Corp Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Celsion Corp - Dist in de afgelopen 3 maanden.

Financieel

Over Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.